A detailed history of Uncommon Cents Investing LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Uncommon Cents Investing LLC holds 12,400 shares of BMY stock, worth $715,232. This represents 0.18% of its overall portfolio holdings.

Number of Shares
12,400
Previous 12,095 2.52%
Holding current value
$715,232
Previous $502,000 27.69%
% of portfolio
0.18%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $12,096 - $15,783
305 Added 2.52%
12,400 $641,000
Q2 2024

Jul 17, 2024

BUY
$40.25 - $52.99 $72,047 - $94,852
1,790 Added 17.37%
12,095 $502,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $60,454 - $68,544
1,260 Added 13.93%
10,305 $558,000
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $180,103 - $214,912
3,715 Added 69.7%
9,045 $464,000
Q3 2023

Oct 19, 2023

BUY
$57.89 - $64.73 $308,553 - $345,010
5,330 New
5,330 $309,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Uncommon Cents Investing LLC Portfolio

Follow Uncommon Cents Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uncommon Cents Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Uncommon Cents Investing LLC with notifications on news.